Search clinical trials for: ABI-009
Total 5956 results
-
EGEN, Inc.CompletedOvarian NeoplasmsUnited States
-
DermBiont, Inc.CompletedTinea VersicolorEl Salvador
-
Mirati Therapeutics Inc.Aadi Bioscience, Inc.Active, not recruitingNSCLC | Metastatic Cancer | Advanced Cancer | Solid Tumor, Adult | Malignant Neoplastic DiseaseUnited States
-
University of WashingtonNational Cancer Institute (NCI); Celgene CorporationCompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Compass TherapeuticsActive, not recruitingMetastatic Colorectal Cancer | Rectal Cancer | Colon CancerUnited States
-
Eisai Co., Ltd.Completed
-
Everfront Biotech Co., Ltd.Not yet recruitingPancreatic Cancer
-
Suzhou Yabao Pharmaceutical R&D Co., Ltd.Completed
-
Coherus Biosciences, Inc.Shanghai Junshi Bioscience Co., Ltd.; Medpace, Inc.Active, not recruitingHepatocellular Carcinoma | Non-Small Cell Lung Cancer | Advanced Solid TumorUnited States
-
University Hospital, LimogesCompletedPeripheral Arterial Disease, Ankle Brachial Index, DopplerFrance
-
CelgeneCompleted
-
Massachusetts Eye and Ear InfirmaryTerminatedBilateral Hearing Loss for Causes Other Than TumorsUnited States
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedSkin Care | Skin | Skin CreamUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States
-
Suzhou Yabao Pharmaceutical R&D Co., Ltd.Not yet recruiting
-
Eleven BiotherapeuticsCompletedA Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1)Allergic ConjunctivitisCanada
-
Massachusetts Eye and Ear InfirmaryTerminatedBilateral Hearing Loss for Causes Other Than TumorsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnRecurrent Bladder Urothelial Carcinoma | Stage IV Bladder Urothelial CarcinomaUnited States
-
Argos TherapeuticsCompletedInflammation | Systemic Lupus Erythematosus (SLE)United States
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Mt. Sinai Medical Center, MiamiBayer; Celgene CorporationCompletedMalignant MelanomaUnited States
-
EyeGene Inc.Novotech (Australia) Pty LimitedActive, not recruiting
-
AstraZenecaPretium Pty LtdCompletedPeripheral Arterial DiseaseAustralia
-
Aadi Bioscience, Inc.Approved for marketingTSC1 | TSC2 | PEComa, Malignant | mTOR Pathway Abberation
-
Jan Biziel University Hospital No 2 in BydgoszczUnknown
-
HanAll BioPharma Co., Ltd.CompletedMild to Moderate Atopic DermatitisUnited States
-
Anne NoonanNational Cancer Institute (NCI)RecruitingStage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic AdenocarcinomaUnited States
-
Inner Mongolia Yili Industrial Group Co., LtdCompletedDyspepsia | Abdominal Pain | Constipation | FlatulenceChina
-
CelgeneTerminatedHemodialysis Graft DysfunctionUnited States
-
University of AarhusOdense University Hospital; Oslo University Hospital; Rigshospitalet, Denmark; Hvidovre... and other collaboratorsCompletedHIV-1-infectionNorway, Denmark, United States, Australia
-
The Cleveland ClinicTerminatedObesity | Peripheral Arterial DiseaseUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingPancreatic Adenocarcinoma | Unresectable Pancreatic Carcinoma | Stage III Pancreatic Cancer AJCC v6 and v7 | Stage IV Pancreatic Cancer AJCC v6 and v7United States
-
Emory UniversityCompletedBreast CancerUnited States
-
Istanbul Training and Research HospitalCompleted
-
Celgene CorporationWithdrawn
-
Bond BiosciencesTerminatedHereditary HemochromatosisAustralia
-
Annexon, Inc.Nucleus Network LtdCompletedSafety and Tolerability in Healthy VolunteersAustralia
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Endometrial Carcinoma | Stage III Bladder Cancer | Cervical Squamous Cell Carcinoma | Stage IV Breast Cancer | Malignant Uterine Neoplasm | Recurrent Bladder Carcinoma | Recurrent... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
M.D. Anderson Cancer CenterCelgeneCompletedColorectal Cancer | Cancer of Gastrointestinal TractUnited States
-
Yanqiao ZhangUnknown
-
Mayo ClinicARYx TherapeuticsCompleted
-
Aadi Bioscience, Inc.National Cancer Institute (NCI)CompletedNon-muscle Invasive Bladder Cancer (NMIBC)United States
-
MorphotekCompletedPancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | MesotheliomaUnited States
-
Celgene CorporationCompleted
-
CelgeneTerminated
-
Sarcoma Oncology Research Center, LLCAadi Bioscience, Inc.CompletedMelanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | Ewing Sarcoma | Non Small Cell Lung Cancer | Chordoma | Urothelial Carcinoma | Classical Hodgkin Lymphoma | PEComa | Desmoid Tumor | Epithelioid Sarcoma | Squamous Cell Carcinoma | MTOR Activating MutationUnited States
-
Memorial Sloan Kettering Cancer CenterBMS FoundationRecruitingPeripheral Arterial Disease (PAD) in Cancer PatientsUnited States
-
SCRI Development Innovations, LLCCelgeneCompletedGastroesophageal CancerUnited States
-
CelgeneUniversity of ArizonaCompletedMalignant MelanomaCanada, United States, Australia, United Kingdom, France, Italy, Spain, Germany, Netherlands